NPs Basic Information
|
Name |
Bulnesene
|
| Molecular Formula | C15H26 | |
| IUPAC Name* |
(3S,3aS,5R)-3,8-dimethyl-5-propan-2-yl-1,2,3,3a,4,5,6,7-octahydroazulene
|
|
| SMILES |
C[C@H]1CCC2=C(CC[C@H](C[C@@H]12)C(C)C)C
|
|
| InChI |
InChI=1S/C15H26/c1-10(2)13-7-5-11(3)14-8-6-12(4)15(14)9-13/h10,12-13,15H,5-9H2,1-4H3/t12-,13+,15-/m0/s1
|
|
| InChIKey |
AAPYGFMEZRXPJI-GUTXKFCHSA-N
|
|
| Synonyms |
bulnesene
|
|
| CAS | NA | |
| PubChem CID | 16679399 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 206.37 | ALogp: | 4.7 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.517 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.518 | MDCK Permeability: | 0.00001580 |
| Pgp-inhibitor: | 0.427 | Pgp-substrate: | 0.007 |
| Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.977 |
| 30% Bioavailability (F30%): | 0.703 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.327 | Plasma Protein Binding (PPB): | 97.10% |
| Volume Distribution (VD): | 5.125 | Fu: | 1.72% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.497 | CYP1A2-substrate: | 0.714 |
| CYP2C19-inhibitor: | 0.327 | CYP2C19-substrate: | 0.914 |
| CYP2C9-inhibitor: | 0.621 | CYP2C9-substrate: | 0.652 |
| CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.173 |
| CYP3A4-inhibitor: | 0.47 | CYP3A4-substrate: | 0.511 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 11.511 | Half-life (T1/2): | 0.091 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.06 |
| Drug-inuced Liver Injury (DILI): | 0.838 | AMES Toxicity: | 0.016 |
| Rat Oral Acute Toxicity: | 0.022 | Maximum Recommended Daily Dose: | 0.022 |
| Skin Sensitization: | 0.781 | Carcinogencity: | 0.443 |
| Eye Corrosion: | 0.963 | Eye Irritation: | 0.983 |
| Respiratory Toxicity: | 0.129 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000808 |  |
0.608 | D04CSZ |  |
0.321 | ||
| ENC001817 |  |
0.439 | D0W3OS |  |
0.235 | ||
| ENC003248 |  |
0.419 | D04ATM |  |
0.222 | ||
| ENC000339 |  |
0.414 | D0K5WS |  |
0.214 | ||
| ENC001072 |  |
0.414 | D0I2SD |  |
0.211 | ||
| ENC003151 |  |
0.397 | D04SFH |  |
0.211 | ||
| ENC003090 |  |
0.390 | D06JPB |  |
0.210 | ||
| ENC002340 |  |
0.390 | D0G8OC |  |
0.210 | ||
| ENC002227 |  |
0.367 | D08SVH |  |
0.206 | ||
| ENC000800 |  |
0.367 | D0N1TP |  |
0.206 | ||